HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$2.68
Day range
$2.55 - $2.72
Year range
$1.15 - $7.13
Market cap
175.76M USD
Avg Volume
333.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.36M | -72.92% |
Net income | -5.50M | 54.04% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.72M | 17.20% |
Total assets | 19.53M | 11.64% |
Total liabilities | 145.73M | 20.87% |
Total equity | -126.20M | — |
Shares outstanding | 65.83M | — |
Price to book | -1.36 | — |
Return on assets | -51.93% | — |
Return on capital | -168.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.50M | 54.04% |
Cash from operations | -6.04M | 52.76% |
Cash from investing | — | — |
Cash from financing | 12.24M | 1,337.96% |
Net change in cash | 6.20M | 151.88% |
Free cash flow | -7.61M | 13.98% |
About
Founded
2000
Headquarters
Website
Employees
9
